HOME >> BIOLOGY >> NEWS
Vioxx in high doses causes hypertension

. There are so many drugs out there," Griffin said. "I personally think that the best thing would be to get rid of the 50-milligram dose, or sell it only in packages of five.

"You hate to make people jump through hoops to get things but it should be harder to prescribe drugs that would potentially do harm."

Others who contributed to the Vanderbilt study were Patrick G. Arbogast, Ph.D., assistant professor of Preventive Medicine; James R. Daugherty, M.S., computer systems analyst in the department; and David J. Graham, M.D., of the U.S. Food and Drug Administration.

Griffin consults for Merck Research Laboratories, part of Merck & Co., Inc., which makes Vioxx, but none of the funding for this study was provided by Merck or any other pharmaceutical company.


'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
13-Jul-2004


Page: 1 2 3

Related biology news :

1. PTEN and prostate cancer--the devil is in the doses
2. Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream
3. UT Southwestern researchers say overdoses of acetaminophen cause most cases of acute liver failure
4. Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers
5. Low doses of radiation in nature may pose more risk
6. Gel may cut doses for some medications
7. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
8. Pollutant causes delayed flowering in plants
9. Disruption of protein-folding causes neurodegeneration, mental retardation
10. Researchers discover why mutant gene causes colon cancer
11. Analysis fingers causes of desertification

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... and software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm ... XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first study ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... pleased to announce the next event in a series of TOPIQ webinars, which ... TOPIQ series of webinars was developed in response to social distancing measures that ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 16, 2020 , ... After ... begins. The completion of a great surgery is only the beginning of a successful ... the research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/18/2020)... ... 2020 , ... dicentra , a leading Contract Research ... is pleased to announce that Charles Galea has joined its clinical trials division ... an accomplished and results-driven sales executive with over 10 years of expertise in ...
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
Breaking Biology Technology:
Cached News: